期刊文献+

药品带量采购对某医院抗精神病药原研药和仿制药使用情况影响 被引量:30

Effects of procuring with target quantity on using antipsychotics at a hospital
原文传递
导出
摘要 目的:分析带量采购对抗精神病药品原研药和仿制药的使用情况影响,为政策制定和医院药事管理提供参考。方法:采用药物经济学方法对带量采购实施前后门诊药房抗精神病药品的数量、金额、用药频度(DDDs)、日均费用(DDC)、仿制药替代率、费用节省等进行分析。结果:带量采购政策实施后,抗精神病药中仿制药使用数量增加4%,仿制药使用金额降低3%。带量采购实施后包含带量采购中选品种的奥氮平片和利培酮片实际费用节省分别为547万元、252万元,占抗精神病药品总节省费用的85.9%,为医保费用节省501万元。结论:本次带量采购政策落地一年,一定程度上解决了药品价格虚高问题,切实降低了部分患者的用药负担,提升了医保基金的使用效率。 OBJECTIVE To explore the effects of pharmaceutical procurement with target quantity of antipsychotics and provide references for policy formulation and hospital drug management.METHODS Pharmacoeconomics was employed for analyzing sales amount,sales volume,defined daily doses(DDDs),defined daily cost(DDC),etc.,before and after policy implementation.RESULTS After implementing policy,the usage volume of generic drugs increased by 4%and the sales amount of generic drugs decreased by 3%.The actual cost savings of olanzapine and risperidone were 5.47 and 2.52 million yuan respectively,accounting for 85.9 percent of the total cost savings of antipsychotics and 5.01 million yuan of medical insurance costs.CONCLUSION After policy implementation,some drug prices have returned to a reasonable level so as to lower the drug expenditure of some patients and enhance the use efficiency of medical insurance fund.
作者 杨琪 果伟 刘珊珊 YANG Qi;GUO Wei;LIU Shan-shan(The National Clinical Research Center for Mental Disorders&Beijing Key Laboratory of Mental Disorders,Beijing Anding Hospital,Capital Medical University,Beijing 100088,China;Advanced Innovation Center for Human Brain Protection,Capital Medical University,Beijing 100069,China)
出处 《中国医院药学杂志》 CAS 北大核心 2021年第4期400-403,418,共5页 Chinese Journal of Hospital Pharmacy
基金 北京市科技计划项目(编号:KY182) 北京市属医院科研培育计划项目(编号:PX2019069)。
关键词 带量采购 抗精神病药 原研药 仿制药 医保费用节省 pharmaceutical procurement with target quantity antipsychotics original drug generic drug savings in medical insurance costs
  • 相关文献

参考文献14

二级参考文献98

  • 1胡永东,崔勇,闫连社,高梅娜.某精神科门诊各种抗抑郁药物的应用频度及费用分析[J].中国临床康复,2005,9(12):32-34. 被引量:5
  • 2Lewis M,McCrone P,Frangou S.Service use and costs of treating schizophrenia with atypical antipsychotics[J].J Clin Psychiatry,2001,62 (10):749.
  • 3颜耀东,黄晓洁,王楠.药品质量标准与药品质量评价相关性的探讨[J].中国药房,2007,18(34):2650-2652. 被引量:17
  • 4Gtllseren L, Cam B, Karako CB, et al. The perceived burden of care and its correlates in schizophrenia [ J]. Turk Psikiyatri Derg, 2010, 21 (3) : 203 -212.
  • 5Murray CJ, Vos T, Lozano R, et al. Disability - adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010 : a systematic analysis for the Global Burden of Disease Study 2010 [ J]. Lancet, 2012, 380 (9859): 2197-2223.
  • 6World Health Organization. The world health report 2011 -Mental health: new understanding, new hope [EB/OL] . [2015-08- 02] . http: //www. who. int/whr/2001/en/.
  • 7de la Fuente JR. The impact of globalization on mental health [ J ].Gac Med Mex, 2012, 148 (6) : 586 -590.
  • 8Lin CY, Tsai GE, Lane HY. Assessing and treating cognitive impairment in schizophrenia: current and future [ J]. Curr Phann Des, 2014, 20 (32): 5127-5138.
  • 9World Health Organization. The global burden of disease : 2004 update [ EB/OL] . [ 2015 - 08 - 02 ] . http: //www. who. int/healthinfo/ global_ burden_ disease/2004_ report_ update/en/.
  • 10Linscott R J, Cross FV. The burden of awareness of psychometric risk for schizophrenia [ J ]. Psychiatry Res, 2009, 166 ( 2/3 ) : 184 -191.

共引文献188

同被引文献347

引证文献30

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部